Humana Inc. (NYSE:HUM) Shares Purchased by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC boosted its stake in Humana Inc. (NYSE:HUM) by 0.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,759 shares of the insurance provider’s stock after buying an additional 42 shares during the period. Mutual of America Capital Management LLC’s holdings in Humana were worth $5,520,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Pinnacle Wealth Management Advisory Group LLC increased its position in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock worth $272,000 after buying an additional 37 shares during the period. Atlas Brown Inc. increased its position in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock worth $1,611,000 after buying an additional 38 shares during the period. Moors & Cabot Inc. increased its position in Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after buying an additional 40 shares during the period. Mather Group LLC. increased its position in Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock worth $60,000 after buying an additional 41 shares during the period. Finally, Capital Advisors Ltd. LLC increased its holdings in shares of Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 43 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HUM. TD Cowen raised their price target on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Piper Sandler raised their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and raised their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. lowered their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Finally, Morgan Stanley lowered their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Trading Down 3.2 %

NYSE:HUM opened at $261.65 on Tuesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The firm has a market capitalization of $31.57 billion, a price-to-earnings ratio of 26.30, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56. The stock has a fifty day simple moving average of $271.23 and a 200 day simple moving average of $285.69.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana’s dividend payout ratio (DPR) is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.